# |
PMID |
Sentence |
1 |
23716685
|
HHLA2 is a member of the B7 family and inhibits human CD4 and CD8 T-cell function.
|
2 |
23716685
|
Here we describe HERV-H LTR-associating protein 2 (HHLA2) as a member of the B7 family that shares 10-18% amino acid identity and 23-33% similarity to other human B7 proteins and phylogenetically forms a subfamily with B7x and B7-H3 within the family.
|
3 |
23716685
|
HHLA2 is expressed in humans but not in mice, which is unique within the B7 and CD28 families.
|
4 |
23716685
|
HHLA2 does not interact with other known members of the CD28 family or the B7 family, but does bind a putative receptor that is constitutively expressed not only on resting and activated CD4 and CD8 T cells but also on antigen-presenting cells.
|
5 |
23716685
|
HHLA2 inhibits proliferation of both CD4 and CD8 T cells in the presence of T-cell receptor signaling.
|
6 |
23716685
|
In addition, HHLA2 significantly reduces cytokine production by T cells including IFN-γ, TNF-α, IL-5, IL-10, IL-13, IL-17A, and IL-22.
|
7 |
23716685
|
Thus, we have identified a unique B7 pathway that is able to inhibit human CD4 and CD8 T-cell proliferation and cytokine production.
|
8 |
23716685
|
HHLA2 is a member of the B7 family and inhibits human CD4 and CD8 T-cell function.
|
9 |
23716685
|
Here we describe HERV-H LTR-associating protein 2 (HHLA2) as a member of the B7 family that shares 10-18% amino acid identity and 23-33% similarity to other human B7 proteins and phylogenetically forms a subfamily with B7x and B7-H3 within the family.
|
10 |
23716685
|
HHLA2 is expressed in humans but not in mice, which is unique within the B7 and CD28 families.
|
11 |
23716685
|
HHLA2 does not interact with other known members of the CD28 family or the B7 family, but does bind a putative receptor that is constitutively expressed not only on resting and activated CD4 and CD8 T cells but also on antigen-presenting cells.
|
12 |
23716685
|
HHLA2 inhibits proliferation of both CD4 and CD8 T cells in the presence of T-cell receptor signaling.
|
13 |
23716685
|
In addition, HHLA2 significantly reduces cytokine production by T cells including IFN-γ, TNF-α, IL-5, IL-10, IL-13, IL-17A, and IL-22.
|
14 |
23716685
|
Thus, we have identified a unique B7 pathway that is able to inhibit human CD4 and CD8 T-cell proliferation and cytokine production.
|
15 |
23716685
|
HHLA2 is a member of the B7 family and inhibits human CD4 and CD8 T-cell function.
|
16 |
23716685
|
Here we describe HERV-H LTR-associating protein 2 (HHLA2) as a member of the B7 family that shares 10-18% amino acid identity and 23-33% similarity to other human B7 proteins and phylogenetically forms a subfamily with B7x and B7-H3 within the family.
|
17 |
23716685
|
HHLA2 is expressed in humans but not in mice, which is unique within the B7 and CD28 families.
|
18 |
23716685
|
HHLA2 does not interact with other known members of the CD28 family or the B7 family, but does bind a putative receptor that is constitutively expressed not only on resting and activated CD4 and CD8 T cells but also on antigen-presenting cells.
|
19 |
23716685
|
HHLA2 inhibits proliferation of both CD4 and CD8 T cells in the presence of T-cell receptor signaling.
|
20 |
23716685
|
In addition, HHLA2 significantly reduces cytokine production by T cells including IFN-γ, TNF-α, IL-5, IL-10, IL-13, IL-17A, and IL-22.
|
21 |
23716685
|
Thus, we have identified a unique B7 pathway that is able to inhibit human CD4 and CD8 T-cell proliferation and cytokine production.
|
22 |
23716685
|
HHLA2 is a member of the B7 family and inhibits human CD4 and CD8 T-cell function.
|
23 |
23716685
|
Here we describe HERV-H LTR-associating protein 2 (HHLA2) as a member of the B7 family that shares 10-18% amino acid identity and 23-33% similarity to other human B7 proteins and phylogenetically forms a subfamily with B7x and B7-H3 within the family.
|
24 |
23716685
|
HHLA2 is expressed in humans but not in mice, which is unique within the B7 and CD28 families.
|
25 |
23716685
|
HHLA2 does not interact with other known members of the CD28 family or the B7 family, but does bind a putative receptor that is constitutively expressed not only on resting and activated CD4 and CD8 T cells but also on antigen-presenting cells.
|
26 |
23716685
|
HHLA2 inhibits proliferation of both CD4 and CD8 T cells in the presence of T-cell receptor signaling.
|
27 |
23716685
|
In addition, HHLA2 significantly reduces cytokine production by T cells including IFN-γ, TNF-α, IL-5, IL-10, IL-13, IL-17A, and IL-22.
|
28 |
23716685
|
Thus, we have identified a unique B7 pathway that is able to inhibit human CD4 and CD8 T-cell proliferation and cytokine production.
|
29 |
23716685
|
HHLA2 is a member of the B7 family and inhibits human CD4 and CD8 T-cell function.
|
30 |
23716685
|
Here we describe HERV-H LTR-associating protein 2 (HHLA2) as a member of the B7 family that shares 10-18% amino acid identity and 23-33% similarity to other human B7 proteins and phylogenetically forms a subfamily with B7x and B7-H3 within the family.
|
31 |
23716685
|
HHLA2 is expressed in humans but not in mice, which is unique within the B7 and CD28 families.
|
32 |
23716685
|
HHLA2 does not interact with other known members of the CD28 family or the B7 family, but does bind a putative receptor that is constitutively expressed not only on resting and activated CD4 and CD8 T cells but also on antigen-presenting cells.
|
33 |
23716685
|
HHLA2 inhibits proliferation of both CD4 and CD8 T cells in the presence of T-cell receptor signaling.
|
34 |
23716685
|
In addition, HHLA2 significantly reduces cytokine production by T cells including IFN-γ, TNF-α, IL-5, IL-10, IL-13, IL-17A, and IL-22.
|
35 |
23716685
|
Thus, we have identified a unique B7 pathway that is able to inhibit human CD4 and CD8 T-cell proliferation and cytokine production.
|
36 |
23716685
|
HHLA2 is a member of the B7 family and inhibits human CD4 and CD8 T-cell function.
|
37 |
23716685
|
Here we describe HERV-H LTR-associating protein 2 (HHLA2) as a member of the B7 family that shares 10-18% amino acid identity and 23-33% similarity to other human B7 proteins and phylogenetically forms a subfamily with B7x and B7-H3 within the family.
|
38 |
23716685
|
HHLA2 is expressed in humans but not in mice, which is unique within the B7 and CD28 families.
|
39 |
23716685
|
HHLA2 does not interact with other known members of the CD28 family or the B7 family, but does bind a putative receptor that is constitutively expressed not only on resting and activated CD4 and CD8 T cells but also on antigen-presenting cells.
|
40 |
23716685
|
HHLA2 inhibits proliferation of both CD4 and CD8 T cells in the presence of T-cell receptor signaling.
|
41 |
23716685
|
In addition, HHLA2 significantly reduces cytokine production by T cells including IFN-γ, TNF-α, IL-5, IL-10, IL-13, IL-17A, and IL-22.
|
42 |
23716685
|
Thus, we have identified a unique B7 pathway that is able to inhibit human CD4 and CD8 T-cell proliferation and cytokine production.
|